SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (2040)11/14/2000 9:27:01 AM
From: scaram(o)uche  Respond to of 52153
 
FT Marketwatch on Biotechs

Oscar Wiener issued a press report, predicting biotech's demise. Nothing happened. It was just after Motley Gruel came out with their "Petfoodexpressshippingcostsincluded.com went broke, so will biotech" editorial, through which biotech continued to rally.

So, Oscar et al., rumored to be a bunch of short little guys with drums, went to Barron's.

Marketwatch, OTOH, uses the "engage brain first" approach to reporting.

I'm sick of slop from Barron's. Really appreciate them creating the ops, however.



To: Jongmans who wrote (2040)11/14/2000 9:56:30 AM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Jongmans,

Yes, another good article from Jesse Schulman. It's great when you get a journalist that actually knows about biotech.

Interesting (but I guess not that surprising) that others are also suggesting the "trickle" idea as the safe way to play biotech.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News